Patents by Inventor Isabelle Dimier-Poisson

Isabelle Dimier-Poisson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOXOPLASMA PLATFORM FOR TREATING CANCER
    Publication number: 20220233607
    Abstract: A strain of an Apicomplexa of the family Sarcocystidae, wherein the strain is replicative and expresses one or more heterologous protein(s) selected from the group including therapeutic proteins, antigens, recombinant surface receptor or combinations thereof, and wherein the strain is selected from the group including Toxoplasma gondii and Neospora caninium. Also, the use of the strain for preventing or treating cancers or infectious diseases in a subject in need thereof.
    Type: Application
    Filed: May 29, 2020
    Publication date: July 28, 2022
    Applicants: UNIVERSITÉ DE TOURS, KYMERIS THERAPEUTICS INC., INSTITUT NATIONAL DE RECHERCHE POUR L'AGRICULTURE, L' ALIMENTATION ET L'ENVIRONNEMENT
    Inventors: Isabelle DIMIER-POISSON, Marie-Noëlle MEVELEC, Anne DI TOMMASO, Nicolas AUBREY, Louis LANTIER, Gordon LEE
  • NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
    Publication number: 20200330568
    Abstract: The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
    Type: Application
    Filed: July 1, 2020
    Publication date: October 22, 2020
    Applicants: UNIVERSITÉ DE TOURS, KYMERIS THERAPEUTICS INC., Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
    Inventors: Isabelle DIMIER-POISSON, Marie-Noëlle MEVELEC, Céline DUCOURNAU, Nathalie MOIRE, Richard MCCRAE
  • for use in treating cancer and infectious diseases
    Patent number: 10736947
    Abstract: The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
    Type: Grant
    Filed: June 8, 2018
    Date of Patent: August 11, 2020
    Assignees: UNIVERSITÉ DE TOURS, KYMERIS THERAPUETICS INC., Institut national de recherche pour l' agriculture, l' alimentation et l'environneement
    Inventors: Isabelle Dimier-Poisson, Marie-Noëlle Mevelec, Céline Ducournau, Nathalie Moire, Richard McCrae
  • NOVEL PEPTIDE STRUCTURES AND USE THEREOF IN THE TREATMENT OF TOXOPLASMOSIS
    Publication number: 20190153083
    Abstract: The invention relates to a peptide structure which does not include a CH1 region, which recognises the SAG1 antigen of Toxoplasma gondii and which can neutralize the invasion of cells by Toxoplasma gondii, and to the use of said structure in the treatment of toxoplasmosis, in particular ocular toxoplasmosis, congenital toxoplasmosis and behavioural disorders linked to the presence of Toxoplasma gondii.
    Type: Application
    Filed: April 11, 2017
    Publication date: May 23, 2019
    Inventors: Matthieu JUSTE, Isabelle DIMIER-POISSON, Nicolas AUBREY, Anne DI TOMMASO
  • NEOSPORA FOR USE IN TREATING CANCER AND INFECTIOUS DISEASES
    Publication number: 20180353580
    Abstract: The present invention relates to a strain of Neospora caninum for use in treating cancer or infectious diseases.
    Type: Application
    Filed: June 8, 2018
    Publication date: December 13, 2018
    Inventors: Isabelle DIMIER-POISSON, Marie-Noëlle MEVELEC, Céline DUCOURNAU, Nathalie MOIRE, Richard MCCRAE
  • Pharmaceutical composition comprising a solid nanoparticle and at least an antigen for the treatment against an intracellular pathogenic agent
    Patent number: 9731005
    Abstract: A pharmaceutical composition for its use in the prophylactic treatment of a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid, without said cationic-polysaccharide core being surrounded by any phospholipidic layer, and at least an antigen obtained from said pathogen.
    Type: Grant
    Filed: September 13, 2013
    Date of Patent: August 15, 2017
    Assignees: UNIVERSITE DE DROIT ET DE SANTE DE LILLE II, UNIVERSITE DE TOURS FRANCOIS RABELAIS, CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LILLE
    Inventors: Didier Betbeder, Isabelle Dimier-Poisson, Céline Ducournau
  • USE OF ATTENUATED PARASITE STRAINS FOR THE PREVENTION AND/OR TREATMENT OF EYE WOUNDS ASSOCIATED WITH AN INFECTION BY TOXOPLASMA GONDII
    Publication number: 20160017275
    Abstract: Strains of Toxoplasma gondii isolated from their natural environment for their use in the prevention and/or the treatment, in a mammal, of ocular lesions associated with an infection by an apicomplexan of the Sarcocystidae family.
    Type: Application
    Filed: March 5, 2014
    Publication date: January 21, 2016
    Inventors: Isabelle DIMIER-POISSON, Gildas LEMEE, Solen MORISSE, Edouard SECHE, Naoual TARFAOUI, Emre YURDUSEV
  • PHARMACEUTICAL COMPOSITION COMPRISING A SOLID NANOPARTICLE AND AT LEAST AN ANTIGEN FOR THE TREATMENT AGAINST AN INTRACELLULAR PATHOGENIC AGENT
    Publication number: 20150238598
    Abstract: A pharmaceutical composition for its use in the prophylactic treatment in a patient against an intracellular pathogen, said composition comprising a solid nanoparticle comprising a porous cationic-polysaccharide solid core, loaded with at least an anionic phospholipid without being surrounded by any phospholipidic layer and at least an antigen obtained from said pathogen.
    Type: Application
    Filed: September 13, 2013
    Publication date: August 27, 2015
    Applicants: UNIVERSITÉ DE DROIT ET DE SANTÉ DE LILLE II, UNIVERSITÉ DE TOURS FRANCOIS RABELAIS, CENTRE HOSPITALIER RÉGIONAL UNIVERSITAIRE DE LILLE
    Inventors: Didier Betbeder, Isabelle Dimier-Poisson, Céline Ducournau